The University of Chicago Header Logo

Connection

Iazsmin Ventura to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Iazsmin Ventura has written about Dose-Response Relationship, Drug.
Iazsmin Ventura
Connection Strength
0.069
Dose-Response Relationship, Drug
  1. COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
    View in: PubMed
    Score: 0.069
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.